Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
Journal of Clinical Oncology (JCO) Podcast - Novel Insights From a Phase II MEK Inhibitor Trial in BRAF Mutant Melanoma

Novel Insights From a Phase II MEK Inhibitor Trial in BRAF Mutant Melanoma

Journal of Clinical Oncology (JCO) Podcast

12/19/12 • 7 min

plus icon
bookmark
Share icon
A discussion of a phase 2 trial of a MEK inhibitor in patients with V600 BRAF mutations and consideration of other relevant results with targeted therapies in this population.

12/19/12 • 7 min

plus icon
bookmark
Share icon

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/journal-of-clinical-oncology-jco-podcast-448/novel-insights-from-a-phase-ii-mek-inhibitor-trial-in-braf-mutant-mela-65956"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to novel insights from a phase ii mek inhibitor trial in braf mutant melanoma on goodpods" style="width: 225px" /> </a>

Copy